Fig. 3
From: GREM1 may be a biological indicator and potential target of bladder cancer
Validation of the bioinformatics results of GREM1: representative IHC staining for GREM1 in BC and adjacent nontumor tissues (A); the expression of GREM1 in unpaired (B) and paired (C) tissues; the correlation between GREM1 expression and clinical parameters: WHO grade (D), Ta_1 (E), smoking history (F), age (G); the prognostic value of GREM1 in IHC data: overall survival (H), cancer-specific survival (I), recurrence-free survival (J); the prognostic value of GREM1 in IHC subgroups: age > 70 years (K), male (L), and Ta_1 (M); WHO: World Health Organization, IHC: Immunohistochemical analysis. ns, P ≥ 0.05; *, P < 0.05; **, P < 0.01; ***, P < 0.001.
